Literature DB >> 12646692

Single-chain Fv multimers of the anti-neuraminidase antibody NC10: the residue at position 15 in the V(L) domain of the scFv-0 (V(L)-V(H)) molecule is primarily responsible for formation of a tetramer-trimer equilibrium.

Olan Dolezal1, Ross De Gori, Mark Walter, Larissa Doughty, Meghan Hattarki, Peter J Hudson, Alexander A Kortt.   

Abstract

Single-chain variable fragment of the murine monoclonal antibody NC10 specific to influenza virus N9 neuraminidase, joined directly in the V(L) to V(H) orientation (scFv-0), forms an equilibrium mixture of tetramer and trimer with the tetramer as the preferred multimeric species. In contrast, the V(H)-V(L) isomer was previously shown to exist exclusively as a trimer. Computer-generated trimeric and tetrameric scFv models, based on the refined crystal structure for NC10 Fv domain, were constructed and used to evaluate factors influencing the transition between V(L)-V(H) trimer and tetramer. These model structures indicated that steric restrictions between loops spanning amino acid residues L55-L59 and L13-L17 from the two adjacent V(L) domains within the V(L)-V(H) trimer were responsible for four scFv-0 molecules assembling to form a tetramer. In particular, leucine at position L15 and glutamate at position L57 appeared to interfere significantly with each other. To minimize this steric interference, the site-directed mutagenesis technique was used to construct several NC10 scFv-0 clones with mutations at these positions. Size-exclusion chromatographic analyses revealed that several of these mutations resulted in the production of NC10 scFv-0 proteins with significantly altered tetramer-trimer equilibrium ratios. In particular, introduction of a polar residue, such as asparagine or threonine, at position L15 generated a highly stable NC10 scFv-0 trimer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646692     DOI: 10.1093/proeng/gzg006

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  10 in total

1.  Highly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabody.

Authors:  Ryutaro Asano; Keiko Ikoma; Yukiko Sone; Hiroko Kawaguchi; Shintaro Taki; Hiroki Hayashi; Takeshi Nakanishi; Mitsuo Umetsu; Yu Katayose; Michiaki Unno; Toshio Kudo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

Review 2.  Continuing pursuit for ideal systemic anticancer radiotherapeutics.

Authors:  Marlein Miranda Cona; Huaijun Wang; Junjie Li; Yuanbo Feng; Feng Chen; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  Invest New Drugs       Date:  2011-10-18       Impact factor: 3.850

3.  Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy.

Authors:  Qingyun Yuan; Qiaoyan Liang; Zujun Sun; Xingxing Yuan; Weihua Hou; Yuxiong Wang; Huijie Wang; Min Yu
Journal:  Oncoimmunology       Date:  2021-07-21       Impact factor: 8.110

4.  Stabilization of the single-chain fragment variable by an interdomain disulfide bond and its effect on antibody affinity.

Authors:  Jian-Xin Zhao; Lian Yang; Zhen-Nan Gu; Hai-Qin Chen; Feng-Wei Tian; Yong-Quan Chen; Hao Zhang; Wei Chen
Journal:  Int J Mol Sci       Date:  2010-12-23       Impact factor: 5.923

5.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

6.  Anti-EGFR scFv tetramer (tetrabody) with a stable monodisperse structure, strong anticancer effect, and a long in vivo half-life.

Authors:  Ryutaro Asano; Noriaki Koyama; Yasuyo Hagiwara; Yosuke Masakari; Ryota Orimo; Kyoko Arai; Hiromi Ogata; Shozo Furumoto; Mitsuo Umetsu; Izumi Kumagai
Journal:  FEBS Open Bio       Date:  2016-05-16       Impact factor: 2.693

7.  Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma.

Authors:  Concetta Quintarelli; Domenico Orlando; Iolanda Boffa; Marika Guercio; Vinicia Assunta Polito; Andrea Petretto; Chiara Lavarello; Matilde Sinibaldi; Gerrit Weber; Francesca Del Bufalo; Ezio Giorda; Marco Scarsella; Stefania Petrini; Daria Pagliara; Franco Locatelli; Biagio De Angelis; Ignazio Caruana
Journal:  Oncoimmunology       Date:  2018-03-15       Impact factor: 8.110

Review 8.  Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing.

Authors:  Gianna M Branella; Harold Trent Spencer
Journal:  Cells       Date:  2021-12-22       Impact factor: 6.600

9.  Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites.

Authors:  Eric C Peterson; Reha Celikel; Kuppan Gokulan; Kottayil I Varughese
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats.

Authors:  Ryutaro Asano; Katsuhiro Hosokawa; Shintaro Taki; Shota Konno; Ippei Shimomura; Hiromi Ogata; Mai Okada; Kyoko Arai; Masayoshi Onitsuka; Takeshi Omasa; Takeshi Nakanishi; Mitsuo Umetsu; Izumi Kumagai
Journal:  Sci Rep       Date:  2020-03-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.